Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Lubica, Roziakova"'
Publikováno v:
OncoReview. 4:185-191
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a653c937744e621b336219fdbf55ea12
https://doi.org/10.5604/20828691.1134300
https://doi.org/10.5604/20828691.1134300
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
L Masakova, Martin Mistrik, Angelika Batorova, Lubica Roziakova, J. Martinka, L Sopko, Bojtarova E
Publikováno v:
Bratislavske lekarske listy. 117(7)
Graft-versus-host disease (GVHD) remains a major problem of allogeneic hematopoietic-stem cell transplantation (HSCT) and an obstacle for successful outcome. Clinically significant acute GVHD (grade II or higher) developed in 20 to 65 percent of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::282bbd56f220858b1d95132f34f09a3c
https://pubmed.ncbi.nlm.nih.gov/27546540
https://pubmed.ncbi.nlm.nih.gov/27546540
Publikováno v:
Bratislava Medical Journal. 113:159-162
Clinical cardiac complications in oncologic patients may develop from subclinical myocardial damage. Biomarkers N-terminal pro brain natriuretic peptide (NT-proBNP) and troponin T (cTnT) have been hypothesized to reflect preclinical cardiotoxicity ea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ede88b69b696f68290f2f99f18da8b80
https://doi.org/10.4149/bll_2012_038
https://doi.org/10.4149/bll_2012_038
Publikováno v:
Neoplasma. 58:1-8
Hematopoietic stem cell transplantation (HSCT) offers patients with malignant and nonmalignant diseases the oportunity to pursue life-prolonging therapy. The number of survivors after successful HSCT is continually increasing. However, HSCT can induc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37798a5425b937920b3364e25fc2aefc
https://doi.org/10.4149/neo_2011_01_1
https://doi.org/10.4149/neo_2011_01_1
Autor:
Beata Mladosievicova, Lubica Roziakova
Publikováno v:
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 18:607-615
The long-term quality of life of patients after hematopoietic stem cell transplantation (HSCT) represents a multidisciplinary problem. HSCT can induce damage of various organs and tissues-from minimal potentially progressive subclinical changes to li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b191944aab1d64335d892db7f24b9b2
https://doi.org/10.3727/096504010x12777678141707
https://doi.org/10.3727/096504010x12777678141707
Autor:
Martin Mistrik, Juraj Dubrava, Jozef Gergel, Bojtarova E, Angelika Batorova, Lubica Roziakova, Peter Kruzliak, Beata Mladosievicova
Publikováno v:
Cardiovascular toxicology. 15(3)
The long-term prognosis of patients after haematopoietic stem cell transplantation (HSCT) has greatly improved. Cardiac complications represent unresolved and potentially life-threatening conditions in these patients. We prospectively examined 37 con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cce09fe3417fe5e060e291186d7d6fc
https://pubmed.ncbi.nlm.nih.gov/25287586
https://pubmed.ncbi.nlm.nih.gov/25287586
Autor:
Martina, Almasi, Lenka, Besse, Lucie, Brozova, Jiri, Jarkovsky, Renata, Bezdekova, Ludek, Pour, Jiri, Minarik, Petr, Kessler, Petr, Pavlicek, Lubica, Roziakova, Miroslav, Penka, Roman, Hájek, Anna, Vasku, Sabina, Sevcikova
Publikováno v:
Journal of the Czech & Slovak Societies for Oncology / Klinická Onkologie; 2018, Vol. 31 Issue 3, p213-229, 17p
The feasibility of an early hospital discharge following chemotherapy for the acute myeloid leukemia
Publikováno v:
Bratislavske lekarske listy. 113(5)
Objective The hospitalization of the patient during the critical myelosuppressive period after chemotherapy is often complicated by infections caused by nosocomial pathogens, what is associated with a high antibiotics consumption and with prolongatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::874c824e7e4e947acdb33b794d351772
https://pubmed.ncbi.nlm.nih.gov/22616589
https://pubmed.ncbi.nlm.nih.gov/22616589
Autor:
Juraj Dubrava, Nadezda Lenkova, Beata Mladosievicova, Bojtarova E, Martin Mistrik, Jozef Gergel, Lubica Roziakova
Publikováno v:
Journal of Experimental & Clinical Cancer Research : CR
Journal of Experimental & Clinical Cancer Research, Vol 31, Iss 1, p 13 (2012)
Journal of Experimental & Clinical Cancer Research, Vol 31, Iss 1, p 13 (2012)
Background Previous therapy with anthracyclines (ANT) and conditioning regimen followed by hematopoietic stem cell transplantation (HSCT) represents a high risk for development of cardiotoxicity. The aim of this study was to assess subclinical myocar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::965df51323365b39a619c98f4084dc74
https://doi.org/10.1186/1756-9966-31-13
https://doi.org/10.1186/1756-9966-31-13